June 2023 Neurology Recall: Biomarker Discovery in Parkinson Disease
Neurology® Podcast
00:00
The Importance of Cerebrospander Fluid Tapping in the Diagnosis of Parkinson's Disease
L'Chila: What would you say remains to be seen in terms of this testing before we could use it clinically for Parkinson's or not. The next steps are the definitive standardization of the method, he says. And so when we jump to the clinical setting I would I would say what I still do with any patient who undergoes a cerebrospander fluid tapping for having a biomarker assessment. L’Chila: We have to convince the patients that this is a cultural battle and they have to be informed about and they should contribute by definition to this to win let's say this battle and also keeping them informed about the advancement of our research terrific to our audience
Transcript
Play full episode
